United States Senate Committee on Commerce, Science & Transportation Home | Graphics On | Site Map | Text Size: A A A Search : + Advanced Search Hearings Markups Nominations Legislative Calendar News Room   » Press Releases   » Op-Eds   » Speeches Audio/Video About the Committee   » Committee History   » Jurisdiction   » Members   » The Chairman   » The Co-Chairman   » Past Chairmen Subcommittees   » Full Committee   » Science, Technology, and Innovation   » Surface Transportation and Merchant Marine Infrastructure, Safety, and Security   » Consumer Affairs, Insurance, and Automotive Safety   » Full Committee   » Oceans, Atmosphere, Fisheries, and Coast Guard   » Space, Aeronautics, and Related Sciences   » Aviation Operations, Safety, and Security   » Interstate Commerce, Trade, and Tourism Contact Information Related Links   » Legislation   » Federal Agencies RSS Feed   Hearings Policy Implications of Pharmaceutical Importation for U.S. Consumers Interstate Commerce, Trade, and Tourism Wednesday, March 7, 2007 09:30 AM SR - 253     Majority Statements Byron L. Dorgan   Witnesses Opening Remarks Panel 1 Dr. Randall Lutter Acting Deputy Commissioner for Policy Food and Drug Administration Panel 2 Hon. Billy Tauzin CEO PhRMA Dr. Stephen Schondelmeyer Professor and Head, Department of Pharmaceutical Care & Health Systems University of Minnesota, College of Pharmacy Mr. William Schultz Partner Zuckerman Spaeder LLP Ms. Nelda Barnett Member, Board of Directors AARP Dr. John Vernon Assistant Professor, Department of Finance University of Connecticut School of Business

Public Information Office: 508 Dirksen Senate Office Bldg • Washington, DC 20510-6125 Tel: 202-224-5115 Hearing Room: 253 Russell Senate Office Bldg • Washington, DC 20510-6125 Home | Privacy Policy | Graphics On | Site Map | Help/Faqs | Search Back to Top